Working…
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Allogeneic ABCB5-positive Stem Cells for Treatment of CVU

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03257098
Recruitment Status : Recruiting
First Posted : August 22, 2017
Last Update Posted : February 19, 2020
Sponsor:
Collaborators:
FGK Clinical Research GmbH
Ticeba GmbH
Granzer Regulatory Consulting & Services
Information provided by (Responsible Party):
RHEACELL GmbH & Co. KG

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : June 2021
Estimated Study Completion Date : June 2021